Julie Wasselin
Centre Hospitalier Universitaire Amiens-Picardie(FR)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies, Renal cell carcinoma treatment, Gastric Cancer Management and Outcomes, COVID-19 Clinical Research Studies
Most-Cited Works
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)(2020)164 cited
- → Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study(2022)16 cited
- → PD-6 Gemcitabine + nab-paclitaxel or gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: A population-based, multicenter AGEO study(2020)1 cited
- → Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study(2022)1 cited
- Comparaison des schémas paclitaxel / ramucirumab et FOLFIRI en 2e ligne de chimiothérapie des adénocarcinomes gastriques métastatiques : étude rétrospective multicentrique(2019)
- → 1854P Multicentric, comparative, retrospective study on the safety and efficacy of conventional chemotherapy in cirrhotic patients with gastrointestinal cancer(2021)
- → 1454P PARAFIRIGAST: Paclitaxel/ramucirumab versus FOLFIRI as second line chemotherapy of metastatic gastric cancer: An AGEO multicenter comparative study with a propensity score analysis(2020)